Abnormalities of cellular immunity and natural killer cells in Gaucher's disease.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of clinical & laboratory immunology

• Publication date

  1987-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2959782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Gaucher's disease and lymphoid malignancy in 2 children.

  2009cited by this paper
• Nonsecretory IgD-kappa multiple myeloma in a patient with Gaucher's disease.

  2009cited by this paper
• Gaucher's disease with monoclonal gammopathy. Significance of splenic plasmacytosis.

  2009cited by this paper
• Correlation of circulating natural killer cell count with prognosis in large cell lymphoma

  1986cited by this paper
• Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and b‐cell proliferations?

  1984cited by this paper
• Coexistence of Gaucher's disease and multiple myeloma.

  1982cited by this paper
• Low natural killer cell activity in patients with malignant lymphoma

  1982cited by this paper
• Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells.

  1982cited by this paper
• Suppressor T cell activity in splenectomized subjects.

  1982cited by this paper
• Natural killer cells: their roles in defenses against disease.

  1981cited by this paper
• Coexistence of IgA myeloma and Gaucher's disease.

  1980cited by this paper
• The association of Gaucher's disease and dysproteinemias.

  1980cited by this paper
• Natural killer funciton in systemic lupus erythematosus.

  1980cited by this paper
• Deficiency of steriod beta-glucosidase in Gaucher disease.

  1975cited by this paper
• Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases.

  1968cited by this paper
• Chediak-Higashi syndrome. Observations on the nature of the associated malignancy.

  1966cited by this paper

• Novel CTSA Variant Identified in a Thai Family With Late‐Infantile Galactosialidosis

  2025cites this paper
• The Role of Killer Ig-like Receptors in Diseases from A to Z

  2025cites this paper
• Leukocyte Imbalances in Mucopolysaccharidoses Patients

  2023cites this paper
• Upregulation of Cytotoxic T-cells in pediatric patients with Gaucher disease

  2022cites this paper
• GBA1 and The Immune System: A Potential Role in Parkinson’s Disease?

  2022cites this paper
• Dendritic cells and monocyte subsets in children with Gaucher disease

  2021cites this paper
• Generation of osteoclasts from type 1 Gaucher patients and correlation with clinical and genetic features of disease.

  2018cites this paper
• A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments

  2017cites this paper
• Activated and Memory T Lymphocytes in Children with Gaucher Disease

  2016cites this paper
• Glucosylceramidases and malignancies in mammals.

  2016cites this paper
• Severe impairment of regulatory T-cells and Th1-lymphocyte polarization in patients with Gaucher disease.

  2015cites this paper
• Serious pulmonary infection in a splenectomized patient with adult type 1 Gaucher disease

  2015cites this paper
• Case Report Serious pulmonary infection in a splenectomized patient with adult type 1 Gaucher disease.

  2015cites this paper
• Recurrent pulmonary aspergillosis and mycobacterial infection in an unsplenectomized patient with type 1 Gaucher disease

  2014cites this paper
• Immunological cells and functions in Gaucher disease.

  2013cites this paper
• KIR genes and HLA class I ligands in Gaucher disease.

  2013influential citation
• Altered innate function of plasmacytoid dendritic cells restored by enzyme replacement therapy in Gaucher disease.

  2013cites this paper
• Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature

  2013cites this paper
• Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis.

  2012cites this paper
• ENVOLVIMENTO DO SISTEMA IMUNE NA DOENÇA DE GAUCHER: análise de variantes dos genes HLA e KIR

  2012cites this paper
• Investigation of the linkage between Gaucher disease and BCelldisorders including multiple myeloma

  2011cites this paper
• Gaucher Disease and Cancer: Concept and Controversy

  2011cites this paper
• Combination therapies for lysosomal storage disease: is the whole greater than the sum of its parts?

  2011cites this paper
• Impact of glycosphingolipid accumulation on the immunological system

  2011cites this paper
• Glucosylceramide in humans.

  2010cites this paper
• Long‐Term Outcomes of Liver Transplantation in Type 1 Gaucher Disease

  2010cites this paper
• Expanding spectrum of the association between Type 1 Gaucher disease and cancers: A series of patients with up to 3 sequential cancers of multiple types—Correlation with genotype and phenotype

  2010cites this paper
• Leukocyte perturbation associated with Fabry disease

  2009cites this paper
• The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients

  2009cites this paper
• Immune system irregularities in lysosomal storage disorders

  2008cites this paper
• Amelioration of hepatic fibrosis via beta-glucosylceramide-mediated immune modulation is associated with altered CD8 and NKT lymphocyte distribution.

  2007cites this paper
• Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease

  2007cites this paper
• [Hematological aspects of Gaucher disease].

  2007cites this paper
• Aspects hématologiques de la maladie de Gaucher: Hematological aspects of Gaucher disease

  2007cites this paper
• Dendritic cells in patients with type I Gaucher disease are decreased in number but functionally normal.

  2006cites this paper
• Gaucher disease and multiple myeloma

  2006cites this paper
• Survey of hematological aspects of Gaucher disease

  2005cites this paper
• Evidence for a link between sphingolipid metabolism and expression of CD1d and MHC‐class II: monocytes from Gaucher disease patients as a model

  2005cites this paper
• Menetrier's disease presenting as an acute protein-losing gastroenteropathy in a 27-year-old man with Gaucher disease

  2005cites this paper
• Research report h-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration

  2005cites this paper
• beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.

  2005cites this paper
• ΠΑΝΕΠΙΣΤΗΜΙΟ ΠΑΤΡΩΝ ΣΧΟΛΗ ΕΠΙΣΤΗΜΩΝ ΥΓΕΙΑΣ

  2005cites this paper
• Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes.

  2005cites this paper
• Effect of enzyme replacement therapy on gammopathies in Gaucher disease.

  2004cites this paper
• Enzyme replacement therapy in the management of longstanding skeletal and soft tissue salmonella infection in a patient with Gaucher’s disease

  2002cites this paper
• Gaucher's Disease. Pathological features.

  1997cites this paper
• 7 Pathological features

  1997cites this paper
• Gammopathy-related crystal-storing histiocytosis, pseudo- and pseudo-pseudo-Gaucher cells. Critical commentary and mini-review.

  1996cites this paper
• Case report: serendipitous Gaucher's disease presenting as elevated erythrocyte sedimentation rate due to monoclonal gammopathy.

  1991cites this paper
• Gaucher's disease: advances and challenges.

  1989cites this paper